Our Services

Clinical Trials

Protocol	Type of Trial	Sponsorship*
Reduced Intensity Conditioning Hematopoietic Cell Transplantation for Pediatric Patients with Hematologic Malignancies at High Risk for Transplant Related Mortality with Standard Transplantation; A Multi-center Trial for the Pediatric Blood and Marrow Transplant Consortium (PBMTC)	Treatment	PBMTC
Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia	Treatment	Limited Institution Pilot
ANBL0032, Phase III Randomized Study of Chimeric Anti-GD2 in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue	Treatment	COG
Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluation Etancercept, Mycophenolate Mofetil (MMF), Denieukin Difitox (Ontak) and Pentostatin in Addition to Corticosteriods	Treatment	BMT CTN
National Marrow Donor Program (NMDP) Recipient Consent for Participation in Research Database and/or Research Sample Respository	Biology	NMDP
GVH0112, Cytokine Gene Polymorphisms in Pediatric Patients Receiving Tacrolimus or Cyclosporin for Graft-versus-Host Disease Prophylaxis	Biology	PBMTC
PBMTC051: Soluble Tumor Necrosis Factor Receptor Embrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome following Allogeneic Stem Cell Transplantation	Treatment	COG

For more information about trial participation, please call 412-692-6740.

*Sponsorships

COG = Children’s Oncology Group
NMDP = National Marrow Donor Program
PBMTC = Pediatric Blood & Marrow Transplant Consortium
BMT CTN = Blood and Marrow Transplant Clinical Trials Network

Last Update
October 12, 2012

top